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esponsibility of InstAbstract To differentiate traditional Chinese medicines (TCM) derived from congeneric species in TCM
compound preparations is usually challenging. The roots of Panax ginseng (PG), Panax quinquefolium (PQ) and
Panax notoginseng (PN) are used as popular TCM. They contain similar triterpenoid saponins (ginsenosides) as
the major bioactive constituents. Thus far, only a few chemical markers have been discovered to differentiate
these three species. Herein we present a multiple marker detection approach to effectively differentiate the three
Panax species, and to identify them in compound preparations. Firstly, 85 batches of crude drug samples
(including 32 PG, 30 PQ, and 23 PN) were analyzed by monitoring 40 major ginsenosides in the extracted ion
chromatograms (EICs) using a validated LC–MS ﬁngerprinting method. Secondly, the samples were clustered
into different groups by pattern recognition chemometric approaches using PLS-DA and OPLS-DA models, and
17 diagnostic chemical markers were discovered. Aside from the previously known Rf and p-F11, ginsenoside
Rs1 could be a new marker to differentiate PG from PQ. Finally, the above multiple chemical markers were used
to identify the Panax species in 60 batches of TCM compound preparations.
& 2016 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of
Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).5
l Association and Institute of Materia
le under the CC BY-NC-ND license
23 1000x2221; fax: þ86 21 5027278
0 8280 2024.
(De-an Guo), yemin@bjmu.edu.cn (




ademy of Medical Sciences and Chinese Pharmaceutical Association.
Figure 1 Structures for 18 ginsenoside reference compounds. Glc,
β-D-glucopyranosyl; Rha, α-L-rhamnopyranosyl; Xyl, β-D-xylopyrano-
syl; Ara (f), α-L-arabinofuranosyl; Ara (p), α-L-arabinopyranosyl,
GlurA, β-D-glucuronopyranosyl.
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The roots of Panax ginseng (PG), Panax quinquefolium (PQ), and
Panax notoginseng (PN) are used as the popular traditional
Chinese medicine (TCM) Ren-Shen, Xiyang-Shen, and San-Qi,
respectively1. Chemical compositions of the three species are very
similar. Nonetheless, PG, PQ and PN are considered to possess
different properties in TCM theory and thus exhibit different
therapeutic functions. PG has the “warm” property and is a good
invigorator; PQ is “cool” and is thus capable of heat-clearing and
refreshing;2 PN is mainly used to dispel stasis and stop bleeding.
These functional varieties may originate from the difference in
chemical composition, particularly in the bioactive triterpenoid
saponins, popularly known as ginsenosides1. However, chemical
difference among the three Panax species has not been fully
clariﬁed thus far. In addition, the market prices differ remarkably
among the Panax species (for instance, between PG and PQ), and
among the same species of different production areas (for instance,
PQ cultivated in China and North America). Taken together, there
is great demand to establish a reliable analytical method to
differentiate the Panax species, and to identify their raw materials
in TCM compound preparations.
Many analytical approaches have been used to identify Panax
species, including DNA barcoding3, Raman or infrared spectro-
photometry4–6, NMR spectroscopy7,8, and LC–MS9–11. Among
these approaches, LC–MS appears to be the most promising one.
Wang et al.10 reported the potential signiﬁcance of two pairs of
ginsenosides (Rg1/Rf and Rc/Rb2) in the differentiation between
PG and PQ by LC/MS/MS analysis. Chan et al.11 later reported the
chemical markers ginsenoside Rf and 24(R)-pseudoginsenoside
F11 together with the intensity ratio of ginsenosides Rg1/Re for
species differentiation of PG and PQ. However, a limited number
of markers may not be able to fully depict the chemical differences
between the three species. The results could be more deﬁnitive by
monitoring multiple markers.
LC–MS-based ﬁngerprinting followed by chemometric analysis
has been increasingly used for TCM analysis, which enables
species differentiation of congeneric plant species12. Direct infu-
sion mass spectrometry combined with chemometric analysis has
been reported to differentiate Panax species13,14. Our previous
study has revealed the potential taxonomic signiﬁcance of certain
ginsenosides (oleanolic acid type, octillol type, malonylated, and
peroxidized ginsenosides) in differentiating PG, PQ, and PN15. In
this work, we present a new approach which integrates LC–MS
based ﬁngerprinting and pattern recognition chemometrics to
discover more marker ginsenosides to differentiate these three
species. These markers were further used in the identiﬁcation of
PG, PQ, and PN in 60 batches of TCM compound preparations.2. Materials and methods
2.1. Chemical reagents and reference standards
Ginsenosides Ro, Ra2, Ra3, Rb1, Rb2, Rc, Rd, Re, Rg1, Rg2, Rf,
20-O-glc-Rf, and notoginsenosides R1, R2, R4 were isolated from
the roots of PG by the authors. Their structures were fully
identiﬁed by NMR analysis15. 20(S)-Ginsenosides Rg3, Rb3, and
24(R)-pseudoginsenoside F11 were purchased from Nanjing
Zelang Medical Technology Co., Ltd. (Nanjing, China). Their
structures are shown in Fig. 1. The purities were495% by LC–MS
analysis. HPLC grade ammonium acetate (Fluka, Sigma–Aldrich,Netherland), formic acid, methanol, acetonitrile (J.T. Baker,
Phillipsburg, NJ, USA) and ultra-pure water prepared using a
Milli-Q water puriﬁcation system (Millipore, MA, USA) were
used for HPLC analysis. Analytical grade methanol and n-butanol
were purchased from Damao Chemical Reagent Factory (Tianjin,
China). The OASIS HLB Cartridge SPE columns were from
Waters Corporation (Milford, MA, USA).
2.2. Plant materials
Crude drug samples of PG were collected from Northeast China or
local Tong-ren-tang drugstores (Beijing, China). PN samples were
collected from Wenshan County, Yunnan Province, China. PQ
samples were purchased from Xushi Yangshen Specialty Co,. Ltd.
(Nanjing, China). Detailed information for the 85 batches of
samples is given in Supplementary Table 1. In addition, 60 batches
of TCM compound preparations which contain PG, PQ or PN
were purchased from local drugstores. Their information is given
in Supplementary Table 2. Voucher specimens are deposited at the
author's laboratory, School of Pharmaceutical Sciences, Peking
University (Beijing, China).
2.3. LC–MS conditions
The LC–MS ﬁngerprints were recorded on a Surveyor HPLC
instrument coupled with a TSQ triple-quadruple tandem mass
spectrometer via ESI interface (Thermo Fisher, San Jose, CA,
USA). The samples were separated on a YMC-Pack ODS-A
column (250 mm  4.6 mm, 5 μm) equipped with an Agilent
Zorbax SB-C18 guard column (12.5 mm  4.6 mm, 5 μm). The
column temperature was maintained at 35 1C. A three-component
mobile phase was used, composed of acetonitrile (A), methanol
(B), and water containing 1 mmol/L ammonium acetate (C). The
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35% B, 53% C; 9 min: 20% A, 30% B, 50% C; 22 min: 35% A,
15% B, 50% C; 35 min: 50% A, 50% C; 45 min: 60% A, 40% C;
50 min: 90% A, 10% C; 55 min: 90% A, 10% C; 58 min: 12% A,
35% B, 53% C. The ﬂow rate was 1 mL/min. For MS detection,
the ESI source was operated in the negative ion mode. The LC
eluant was introduced into the mass spectrometer at a post-column
splitting ratio of 5:1. Ultra-high purity helium (He) and high purity
nitrogen (N2) were used as the collision gas and nebulizing gas,
respectively. The analyzer scanned over m/z 400–1500 in the full
scan mode. An optimal source fragmentation voltage of 20 V was
applied to suppress the adducted precursor ions. Using ginseno-
sides Re (protopanaxatriol type) and Rb2 (protopanaxadiol type) as
reference compounds, the capillary voltage and tube lens offset
voltage were optimized as –22 and –60 V, respectively. Ionspray
voltage, 4.5 kV; sheath gas (N2), 45 arbitrary units; auxiliary gas
(N2), 10 units; capillary temperature, 320 1C. To further identify
the peaks in the LC–MS ﬁngerprints, the samples were analyzed
by LC–ESI-MSn and LC–qTOF-MS, as described in Supplemen-
tary Information Sections 1 and 2.
2.4. Sample preparation
Ultrasound-assisted extraction was used to prepare the herbal
extract samples. An aliquot of 0.2 g ﬁnely ground dry powder was
soaked in 10 mL of 50% aqueous methanol (v/v) for 30 min before
extraction for 40 min at 40 1C. The extract was centrifuged at
4000 rpm for 15 min (Thermo Multifuge 1S-R, Thermo Fisher
Scientiﬁc, MA, USA), and the supernatant was ﬁltered through a
0.22-μm microporous membrane to obtain the test solution. An
aliquot of 10 mL of the test solution was injected for analysis. The
test solutions of TCM compound preparations were obtained in a
similar manner, as described in Supplementary Information
Section 3.
2.5. Multivariate data analysis
The peak areas for 40 major ginsenosides (marked in blue in
Fig. 2) in the extracted ion chromatograms (EICs) were used as
variables for multivariate data analysis. The peak areas wereFigure 2 The LC–(–)ESI-MS TIC chromatograms for reference stan
P. quinquefolium (D), and P. notoginseng (E). The peak areas for 40 ginsen
52, 55, 56–62, 65, 66, 68, 70–72, 76, 77, 83–87) were used as variables for
Re (17), S4: Rg1 (18), S5: Ro (22), S6: Rf (35), S7: p-F11 (38), S8: noto-R
S13: Rb1 (60), S14: Rc (62), S15: Rb2 (65), S16: Rb3 (66), S17: Rd (71)normalized to their sum values to minimize the deviation caused
by system instability or different drug concentration. The normal-
ized peak areas of 40 peaks in the 85 batches of crude drug
samples were used to generate a 2D data lattice, which was
subsequently imported into SIMCA-P 13.0 (Umetrics AB. Umeå,
Sweden) for chemometric analysis. PLS-DA and OPLS-DA
models were used for pattern recognition. The variables were
pareto-scaled prior to automatic ﬁtting. The variable importance in
projection (VIP) plot, which directly reﬂects the contribution of
each variable, together with a two-tailed t-test, were used to
identify potential marker compounds. Characteristic markers were
deﬁned for those only detectable in one unique species, whereas
the signiﬁcantly differential markers should exhibit top-5 VIP
values and statistical signiﬁcance between two groups (Po 0.05).3. Results and discussion
3.1. Optimization of LC–MS conditions
An LC–MS-based ﬁngerprinting method was established to
analyze the chemical constituents of PG, PQ, and PN. The sample
preparation procedure, chromatographic conditions, and MS detec-
tion parameters were optimized to achieve baseline separation of
similar ginsenosides and sensitive detection of minor compounds.
The method was validated in terms of inter-day and intra-day
variation and reproducibility. The details were described in
Supplementary Information Sections 4 and 5.
3.2. Identiﬁcation of chromatographic peaks
Based on the fragmentation pathways of 18 reference ginsenosides
derived from an ion-trap mass spectrometer, a total of 87
chromatographic peaks were identiﬁed or putatively characterized.
The fragmentation pathways were described in Supplementary
Information Section 6, and the fragments for representative 20(S)-
protopanaxadiol (PPD) type (Ra3), 20(S)-protopanaxatriol (PPT)
type (20-O-glucosyl-Rf), and oleanolic acid (OA) type (Ro)
ginsenosides were illustrated in Supplementary Fig. 1. Detailed
information of identiﬁed ginsenosides is given in Supplementarydards (A), P. ginseng (B), steamed P. ginseng (red ginseng, C),
osides (10, 11, 17, 18, 22, 25, 27–29, 32, 34, 35, 37, 38, 41, 47, 48, 51,
multivariate data analysis. S1: 20-O-glc-Rf (10), S2: noto-R1 (11), S3:
2 (41), S9: Rg2 (48), S10: noto-R4 (51), S11: Ra2 (58), S12: Ra3 (59),
, S18: 20(S)-Rg3 (84).
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18, 22, 35, 38, 41, 48, 51, 58, 59, 60, 62, 65, 66, 71, and 84 were
unambiguously identiﬁed by comparing the retention time (tR),
MS and MS/MS product ions with those obtained by reference
compounds. Here we take peaks 25, 68, 70 and 72 as examples to
clarify the identiﬁcation process. Other ginsenosides were identi-
ﬁed following the same manner (Supplementary Table 3).
Peak 25 (tR 21.37 min), a common peak for PG, PQ and PN,
had a molecular formula of C47H74O18 (m/z 925.4803 for
[C47H73O18]
–, mass error 0.11 ppm). The deprotonated precursor
ion (m/z 925) fragmented into m/z 613 ([M–H–Glc–Xyl–H2O]
–)
and 569 ([M–H–Glc–Xyl–H2O–CO2]
–) (Fig. 3). The product ion
m/z 455 ([OA–H]–), dissociated from m/z 569, suggested a
possible OA sapogenin. In the positive ion mode, CID of the
sodium-adduct precursor m/z 949 generated the same Y0β
þ (m/z 641
for [MþNa–Xyl–GlurA]þ) and Z0βþ (m/z 623 for
[MþNa–Xyl–GlurA–H2O]þ) product ions as those of Ro
(Supplementary Fig. 1), which indicated the presence of a 3-
GlurA-Xyl disaccharide chain. The structure difference between
peak 25 and Ro was a pentose instead of a hexose (Glc) at the
terminal of 3-sugar chain. Moreover, peak 25 was eluted later than
Ro (tR 21.37 versus 18.05 min), in agreement with its relatively
lower polarity than Ro. These data supported the identiﬁcation of
25 as chikusetsusaponin IV (OA-28-Glc-3-GlurA-Xyl)16.
Among the three acetyl-substituted ginsenosides (68, 70, and
72), peak 68 (tR 37.97 min) was characterized as PPD-20-GlcGlc-
3-GlcGlc-acetyl, while peaks 70 (tR 39.14 min) and 72 (tR
40.30 min) were both PPD-20-GlcXyl-3-GlcGlc-acetyl. In the
extracted ion chromatograms, both the elution order and relative
abundance of these three peaks were in agreement with those for
Rb1, Rc, and Rb2 (Supplementary Fig. 2). Therefore, peaks 68, 70,
and 72 were characterized as Ac-Rb1 (quinquenoside R1), Ac-Rc
(ginsenoside Rs2), and Ac-Rb2 (ginsenoside Rs1), respec-
tively17,18. For all the ginsenosides characterized in PG, PQ and
PN, the acetyl, malonyl or butenoyl group was substituted at 3-OH
sugar chain for PPD type compounds or 6-OH sugar chain for PPT
type, except for peak 2.3.3. Discovery of marker compounds to differentiate among PG,
PQ, and PN
3.3.1. Differentiation between PG and PQ
Several studies have compared the chemical composition of PG and
PQ. The two major marker compounds that could discriminate the
two species were ginsenoside Rf and 24(R)-pseudoginsenoside-F11
(p-F11).
19,20 Our results were consistent with these studies, where Rf
(35) and p-F11 (38) were only detected in PG and PQ, respectively.Figure 3 ESI-MSn spectra in negative and positive ion modesIn addition, a potential new marker compound, tentatively identiﬁed
as ginsenoside Rs1 (72, Ac-Rb2), was found characteristic for PG.
Fig. 4 exhibits the remarkably differential content of Rs1 between
PG and PQ. Therefore, Rf and Rs1 were considered as the
characteristic markers for PG, whereas p-F11 was characteristic
for PQ.
Chemometric analysis was then applied to identify ginsenosides
capable of differentiating PG and PQ. The established OPLS-DA
model, with good ﬁtness (R2X 0.575, R2Y 0.983) and predictability
(Q2 0.979), enabled good separation of PG and PQ groups
(Fig. 5A). Two outliers (W11 and W12) were observed, but still
segregated from the PQ group. The VIP plot could directly reﬂect
the contribution level of the variables to group classiﬁcation21,22.
A cutoff VIP value of 1.3 identiﬁed nine major potential marker
ginsenosides: p-F11 (38), chikusetsusaponin IV (25), 20-O-glc-Rf
(10), Rf (35), Re (17), Rb2 (65), Rb1 (60), Rg2 (48), and m-Rd
(47) (Fig. 5B). The fact that Rs1 was not ranked among top-9
variables could be due to its low content in both PG and PQ. All
the nine variables showed statistical signiﬁcance between PG and
PQ by a two-tailed t-test (type 3). Finally, we identiﬁed three
characteristic markers (Rf, p-F11, and Rs1) and ﬁve signiﬁcantly
differential markers (chikusetsusaponin IV, 20-O-glc-Rf, Re, Rb2,
and Rb1) to differentiate PG and PQ.3.3.2. Differentiation between PG and PN
The same procedure was employed to discover potential markers
to discriminate PG from PN. Ginsenosides Ro (22), m-Rc (32) and
m-Rb2 (37) were detected as common peaks for all PG samples,
but not detected in PN. However, no characteristic peak was found
for PN. Using the 40 ginsenosides as variables for multivariate
data analysis, p-F11 was not detected in either PG or PN samples,
and was thus excluded from the dataset. Here we applied PLS-DA
for model ﬁtting since over-ﬁtting was observed when using the
OPLS-DA model (Supplementary Fig. 3). The PLS-DA model was
efﬁcient to separate the samples into two different groups with
good ﬁts to the underlying models (R2X 0.606; R2Y 0.984) and
excellent predictability (Q2 0.982) (Fig. 5C). However, W11 and
W12 were also outliers, which was consistent with PG and PQ.
Ten variables displayed VIP values of higher than 1.3 in the VIP
plot (Fig. 5D), including noto-R1 (11), Rc (62), Rg1 (18), Rd (71),
Rf (35), Rb2 (65), Ro (22), Rb1 (60), Rb3 (66), and noto-K (76).
All these ten variables showed signiﬁcant difference between PG
and PN (Po 0.001). The characteristic components, Ro, m-Rc,
and m-Rb2, and ﬁve most signiﬁcantly differential components
(noto-R1, Rc, Rg1, Rd, and Rf) were selected as markers to
discriminate PG and PN.for chikusetsusaponin IV (OA-28-Glc-3-GlurA-Xyl, 25).
Figure 4 Extracted ion chromatograms for ginsenoside Rs1 ([M–H]
−, m/z 1119.5), a potential characteristic marker to differentiate P. ginseng
and P. quinquefolium. The chromatograms for 20 batches of P. ginseng and 20 batches of P. quinquefolium samples are shown. W and R refer to
air-dried and steamed P. ginseng (white and red ginseng), respectively; Q refers to P. quinquefolium.
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Relatively obvious differences were observed between PQ and PN
(Fig. 2). Based on the analysis of EIC for 30 PQ and 23 PN
samples, we found that Ro (22) and p-F11 (38) were characteristic
markers for PQ, whereas Rf (35) and Ra3 (59) were characteristic
for PN. Compounds m-Ra2 (27), m-Ra3 (28), m-Ra1 (34), Rs1
(72), Ra2 (58), peaks 52, 57, and 77 were not present or very low
in both PQ and PN. Thus, the other 32 compounds were analyzed
as variables using the OPLS-DA model. As shown in Fig. 5E, two
obvious groups were separated. When the VIP boundary was set as
1.2, seven compounds were discovered, corresponding to noto-R1
(11), noto-R2 (41), Rg1 (18), 20-O-glc-Rf (10), p-F11 (38), Ro
(22), and Re (17) (Fig. 5F). They all exhibited signiﬁcant
difference between PQ and PN. Four characteristic markers for
PQ (Ro and p-F11) and PN (Rf and Ra3), together with ﬁve
signiﬁcantly differential markers (noto-R1, noto-R2, Rg1, 20-O-
glc-Rf, and Re), were ﬁnally identiﬁed to differentiate PQ and PN.
Based on the above analyses, we were able to summarize the
following points to rapidly differentiate the three Panax species
(Fig. 6, Supplementary Table 3): (1) Ginsenoside Rs1 is unique for
PG, while p-F11 is characteristic for PQ; (2) The presence of Ro,
Rf, Ra3, Rs1, m-Rc, m-Rb2, and the absence of p-F11 are
diagnostic for PG; the presence of p-F11, Ro, and the absence of
Rf, Rs1, Ra3 could allow the identiﬁcation of PQ. PN contains Ra3,
but not p-F11, Rs1, Ro, m-Rc, and m-Rb2; (3) Ginsenosides 20-O-glc-Rf, Re, Rg1, Rc, Rb2, and Rd are rich in PG; Re and Rd are
abundant in PQ; noto-R1, Rg1, and Rd are abundant in PN.3.4. Identiﬁcation of the three Panax species in TCM compound
preparations
In total 17 diagnostic chemical marker compounds, including
7 characteristic markers (Rf, Rs1, p-F11, Ro, m-Rc, m-Rb2, and
Ra3, species speciﬁc) and 10 signiﬁcantly differential markers
(chikusetsusaponin IV, 20-O-glc-Rf, Re, Rb2, Rb1, Rc, Rg1, Rd,
noto-R1, and noto-R2, showing signiﬁcant abundance variance
between species) were discovered. These markers were used to
identify PG, PQ, and PN in 40 different TCM compound
preparations (60 batches).
All 60 batches of samples were analyzed by LC–MS, and the
peak areas for the markers were obtained by extracting the [M–H]–
ions. For the 7 characteristic markers, their presence or absence
was used to identify the Panax species. For the 10 signiﬁcantly
differential markers, the relative peak area ratios for each
compound in the extracted ion chromatograms against that of
Rb1 were calculated. The results are shown in Supplementary
Table 4.
By monitoring multiple diagnostic chemical markers, the Panax
species used for the manufacturing of TCM compound
Figure 5 Statistic analyses and discovery of potential markers to differentiate PG/PQ, PG/PN, and PQ/PN. PG, P. ginseng; PQ, P.
quinquefolium, PN, P. notoginseng. (A) OPLS-DA score plot of PG and PQ; (B) VIP plot of PG and PQ showing 9 signiﬁcantly differential
components while VIP cutoff was set at 1.3; (C) PLS-DA score plot of PG and PN; (D) VIP plot of PG and PN showing 10 signiﬁcantly
differential components with VIP values higher than 1.3; (E) OPLS-DA score plot of PQ and PN; (F) VIP plot of PQ and PN showing
7 signiﬁcantly differential components while VIP cutoff was set at 1.2.
Figure 6 Extracted ion chromatograms of the 17 diagnostic chemical markers to differentiate PG, PN and PQ crude drugs.
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Wenzhi Yang et al.574preparations could be identiﬁed. Among the 40 preparations we
analyzed, the identiﬁcation results were consistent with the
speciﬁed species for 37 preparations. The only two exceptions
were Wu-ji-bai-feng Pills (A6) and Sheng-mai-yin (B1). Although
their chemical patterns were mostly similar to P. ginseng (which
was the speciﬁed species), they showed very weak chromato-
graphic peaks, and several marker compounds were not detected.
Sample A8 (Yi-nian-jin) could be identiﬁed to contain P. ginseng
according to its multi-marker chemical pattern. Two characteristic
markers for PG (m-Rc and m-Rb2) were not detected, probably
due to poor thermostability of malonyl ginsenosides23. Similarly,
C13 (Wei-kai-ling Capsules) and C14 (Jin-kang Capsules) could
be identiﬁed to contain PN, by analyzing their multi-marker
patterns, though the signals for ginsenoside Rf were very weak.
In traditional Chinese medicine, the roots of P. ginseng could be
used as white ginseng (dried after collection) or red ginseng
(processed by steaming). By using the multiple chemical markers
discovered in this study, both white and red ginseng could be
correctly identiﬁed as P. ginseng. However, these two types could
not be differentiated from each other.4. Conclusions
To effectively differentiate the three Panax species, PG, PQ and
PN, an LC–MS-based ﬁngerprinting method coupled with multi-
variate data analysis was established. The peak areas for 40
ginsenosides were used for pattern recognition chemometric
analysis by PLS-DA and OPLS-DA. A total of 17 diagnostic
chemical marker compounds, including 7 characteristic markers
(Rf, p-F11, Ro, Rs1, Ra3, m-Rc, and m-Rb2, species speciﬁc) and
10 signiﬁcantly differential markers (20-O-glc-Rf, chikusetsusa-
ponin IV, Re, Rg1, Rd, Rc, Rb2, noto-R1, noto-R2, and Rb1,
showing signiﬁcant abundance variance between species) were
discovered to differentiate PG, PQ, and PN. Ginsenoside Rs1 could
be a new marker to differentiate PG and PQ. By monitoring the
above multiple diagnostic markers, the Panax species in 60
batches of TCM compound preparations could be effectively
identiﬁed.
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